praxis-text-mobile

COVID Clinical Trials: Investigation for Investigation’s Sake?

In the rush to find a treatment for #Covid19, we’ve seen a huge influx of new #clinicaltrials, largely of repurposed drugs. Many of these trials are small and unlikely to prove or disprove efficacy in a significantly meaningful way. Yet, studies are approved, participants are enrolled and resources wasted, as for some players, the cash […]